Yeijin Kim, Pharm.D., M.S.

Yeijin Kim smiling in front of a gray background

Graduate Student

Advising Professor(s): Dr. Chanhyun Park

Education

  • M.S. Pharmaceutical Economics, Big Data Analytics & Policy, Kyung Hee University
  • Pharm.D., Kyungsung University 

Research Interests

  • Clinical Outcomes, Health Disparities/ Health Equity, Patient-Reported Outcomes, Pharmacoepidemiology, Real World Data & Information Systems, Social Determinants of Health

Publications

  • Kim Y, Lee J, Suh HS, Park C. Response to letter to the editor: Cardiovascular and cancer-specific mortality in older patients with advanced non-small cell lung cancer following the introduction of immuno-oncology therapies. Journal of Geriatric Oncology, 2026; 17(3).
  • Yoon H*, Kim Y*, Han S, Suh HS, Park C. Long-Term Survival Prediction in Older Women With Stage I-II Breast Cancer Using Decision Tree-based Machine Learning. Journal of Geriatric Oncology. 2026; 17(2). (* co-first author)
  • Kim Y, Lee J, Suh HS, Park C. Cardiovascular and cancer-specific mortality in older patients with advanced non-small cell lung cancer following the introduction of immuno-oncology therapies. Journal of Geriatric Oncology. 2026; 17(1).
  • Kim Y, Liu Y, Suh HS, Park C. Factors Associated with Cause-Specific Mortality in Older Patients with Advanced NSCLC Treated with PD-1 Inhibitors. Cancer Control. 2025;32.
  • Le N, Han S, Kenawy AS, Kim Y, Park C. Machine Learning-Based Prediction of Unplanned Readmission Due to Major Adverse Cardiac Events Among Hospitalized Patients with Blood Cancers. Cancer Control. 2025;32:10732748251332803. 
  • Kim Y, Han S, Suh HS. The impact of migraine and probable migraine on productivity loss in Korea: A cross-sectional online survey. PLoS One. 2022 Nov 28;17(11):e0277905. doi: 10.1371/journal.pone.0277905. PMID: 36441801; PMCID: PMC9704660.

Presentations

  • Wu LW, Kim Y, Park C. Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Among Older Women with Breast Cancer in the 2011-2021 SEER-Medicare Data. ISPOR 2026. May 17-20, 2026. Philadelphia, PA.
  • Kim Y, Wu LW, Kumaraswamy N, Park C. Algorithmic Fairness in Machine Learning Prediction for Long-Term Adjuvant Endocrine Therapy Adherence among Breast Cancer Survivors. ISPOR 2026. May 17-20, 2026. Philadelphia, PA.
  • Welter E, Mann A, Kim Y, Park C. Impact of a positive formulary change on antiretroviral therapy adherence in members with human immunodeficiency virus. AMCP 2026. Apr 13-16, 2026. Nashville, TN.
  • Kim Y, Giroux M, Park C. Real-World Evidence on Health-Related Quality of Life in Older Women with Advanced Breast Cancer Treated with CDK 4/6 Inhibitors. ISPOR 2025. May 13-16, 2025. Montreal, Canada.
  • Lee J, Kim Y, Suh HS. Impact of Smoking History on the Real-World Effectiveness of Immune Checkpoint Inhibitors in Previously Treated Non-Small Cell Lung Cancer: A Nationwide Population-Based Study. ISPOR Europe 2024. Nov 17-20, 2024. Barcelona, Spain.
  • Le N, Han S, Kim Y, Park C. Machine Learning-Based Prediction of Unplanned Readmission Due to Major Adverse Cardiovascular Events (MACE) Among Hospitalized Patients With Blood Cancers. ISPOR 2024. May 5-8, 2024. Atlanta, Georgia.
  • Kim Y, Lee J, Suh HS, Park C. Changing treatment landscape, survival and cause of death of elderly patients with advanced non-small cell lung cancer in the immunotherapy era: A population-based real-world study in the United States and South Korea. ISPOR 2024. May 5-8, 2024. Atlanta, Georgia.
  • Kim Y, Park C, Suh HS. Cardiovascular disease mortality risk in older patients with advanced non-small cell lung cancer using PD1/PD-L1 inhibitors. ISPOR 2024. May 5-8, 2024. Atlanta, Georgia.
  • Kim Y, Suh HS. Effect of Daratumumab on Pneumonia in Patients with Multiple Myeloma Using Population based Real-World Data. ISPOR Europe 2023. Nov 12-15,2023. Copenhagen, Denmark.
  • Oh J, Kim Y, Suh HS. Medication Treatment Pathways in Chronic Urticaria patients from electronic health record using OMOP-CDM (common data model). Poster presentation, the 2022 Fall International Convention of the Pharmaceutical Society of Korea. Jeju Island, Republic of Korea. October 2022.
  • Kim D, Choi K, Kim Y, Suh HS. The effect of expanding reimbursement criteria for G-CSF injections in cancer patients: An interrupted time series. Poster presentation, the 2022 Fall International Convention of the Pharmaceutical Society of Korea. Jeju Island, Republic of Korea. October 2022.
  • Kim Y, Han S and Suh HS. Productivity Loss and Indirect Costs Associated with Migraine and Probable Migraine in Korea. Poster presentation, the 2022 International Society for Pharmacoeconomics and Outcomes Research. Washington, DC, USA. May 2022.
  • Ju HE, Kim Y, Choi K, Suh HS. Antiepileptic medication treatment pathways in adults from the electronic health record using the common data model. Poster presentation, the 2021 Fall International Convention of the Pharmaceutical Society of Korea. Jeonju, Republic of Korea. December 2021.

Internships

  • GRA, St. David’s CHPR Pilot Research Grant (PI: Dr. Chanhyun Park) [2025–2026]

Contact Information